NXTC · NextCure, Inc.

Summary

NextCure, Inc. reported full year 2025 financial results, including a net loss of $55.8 million and cash position of $41.8 million as of December 31, 2025, sufficient to fund operations into the first half of 2027. The company provided business updates on SIM0505 and LNCB74 clinical programs with key milestones anticipated in 2026.

Key takeaways

• Event Type: Earnings Release and Business Update (Items: 2.02)